{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:15:51Z","timestamp":1791422151420,"version":"4.3.3"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/mcg.0b013e318297fa65","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T10:27:15Z","timestamp":1368786435000},"page":"684-688","source":"Crossref","is-referenced-by-count":33,"title":["Serum HMGB1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma"],"prefix":"10.1097","volume":"47","author":[{"given":"Chiharu","family":"Tabata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Masachika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ichiro","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma.","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"R2-7-20210305","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma.","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"R3-7-20210305","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"R4-7-20210305","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L","article-title":"Latency of asbestos disease among insulation workers in the United States and Canada.","volume":"15","author":"Selikoff","year":"1980","journal-title":"Cancer"},{"key":"R5-7-20210305","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review.","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"R6-7-20210305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jso.21055","article-title":".Consensus statement on peritoneal mesothelioma.","volume":"98","author":"Deraco","year":"2008","journal-title":"J Surg Oncol"},{"key":"R7-7-20210305","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":".Malignant peritoneal mesothelioma: a multicenter study on 81 cases.","volume":"21","author":"Manzini Vde","year":"2010","journal-title":"Ann Oncol"},{"key":"R8-7-20210305","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.21787","article-title":"Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.","volume":"103","author":"Baratti","year":"2011","journal-title":"J Surg Oncol"},{"key":"R9-7-20210305","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":".Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R10-7-20210305","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":".Mesothelin-family proteins and diagnosis of mesothelioma.","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"R11-7-20210305","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":".Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"R12-7-20210305","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjc.6604879","article-title":".Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study.","volume":"100","author":"Rake","year":"2009","journal-title":"Br J Cancer"},{"key":"R14-7-20210305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"R15-7-20210305","doi-asserted-by":"crossref","first-page":"L1427","DOI":"10.1152\/ajplung.00075.2007","article-title":".The role of the receptor for advanced glycation end-products in lung fibrosis.","volume":"293","author":"He","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R16-7-20210305","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2007-0330OC","article-title":".The role of high mobility group box1 in pulmonary fibrosis.","volume":"39","author":"Hamada","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R17-7-20210305","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":".Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma.","volume":"72","author":"Jube","year":"2012","journal-title":"Cancer Res"},{"key":"R18-7-20210305","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/MCG.0b013e31824e901b","article-title":".Serum thioredoxin-1 as a diagnostic marker for malignant peritoneal mesothelioma.","volume":"47","author":"Tabata","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R19-7-20210305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R20-7-20210305","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":".The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Clin Invest"},{"key":"R21-7-20210305","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20052203","article-title":".Role of HMGB1 in apoptosis-mediated sepsis lethality.","volume":"203","author":"Qin","year":"2006","journal-title":"J Exp Med"},{"key":"R23-7-20210305","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","article-title":".High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.","volume":"48","author":"Taniguchi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R24-7-20210305","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200712-1894OC","article-title":".Potential role of high-mobility group box 1 in cystic fibrosis airway disease.","volume":"178","author":"Rowe","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-7-20210305","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","article-title":".Masquerader: high mobility group box-1 and cancer.","volume":"13","author":"Ellerman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R26-7-20210305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","article-title":"3rd, et al..High-mobility group box 1 and cancer.","volume":"1799","author":"Tang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R27-7-20210305","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":".Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"key":"R28-7-20210305","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/MCB.23.8.2991-2998.2003","article-title":".Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.","volume":"23","author":"Poser","year":"2003","journal-title":"Mol Cell Biol"},{"key":"R29-7-20210305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.2004.062729","article-title":".Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.","volume":"55","author":"Volp","year":"2006","journal-title":"Gut"},{"key":"R30-7-20210305","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1096\/fj.02-0621fje","article-title":".HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma.","volume":"17","author":"Brezniceanu","year":"2003","journal-title":"FASEB J"},{"key":"R31-7-20210305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1165\/rcmb.2009-0269OC","article-title":".High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.","volume":"43","author":"Liu","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R32-7-20210305","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.0604008103","article-title":".TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis.","volume":"103","author":"Yang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-7-20210305","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":".Malignant mesothelioma: facts, myths, and hypotheses.","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol"},{"key":"R34-7-20210305","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.","volume":"18","author":"Carbone","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R35-7-20210305","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","article-title":".Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-7-20210305","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":".Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0b013e318297fa65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:12:01Z","timestamp":1620961921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201309000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e318297fa65","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}